Ecnoglutide vs Semaglutide

Ecnoglutide is an experimental GLP-1 receptor agonist still in development, with no FDA approvals yet. Semaglutide, an approved GLP-1 receptor agonist, is sold under brand names like Ozempic, Wegovy, and Rybelsus and is FDA-approved to treat type 2 diabetes, obesity, chronic kidney disease, and cardiovascular risk reduction.

AI summary of the sources below.